or Try an Advanced Search...

    Technical Analysis for DXB - Dimerix Ltd  

    Grade Last Price % Change Price Change
    F 0.325 -2.99% -0.010
    DXB closed down 2.99 percent on Thursday, November 21, 2024, on 70 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical DXB trend table...
    Date Alert Name Type % Chg
    Expansion Breakdown Bearish Swing Setup 0.00%
    Hammer Candlestick Bullish 0.00%
    Stochastic Buy Signal Bullish 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Below Lower BB Weakness 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Lower Bollinger Band Walk Weakness -2.99%
    Older End-of-Day Signals for DXB ...

       Recent Intraday Alerts

    Alert Time
    Reversed from Down about 18 hours ago
    Down 10% about 18 hours ago
    Down 1 ATR about 18 hours ago
    Rose Above Lower Bollinger Band about 18 hours ago
    Fell Below Previous Day's Low about 18 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    DXB Chart by TradingView
    Basic chart:

    Profile

    Dimerix Bioscience Ltd, formerly Dimerix Bioscience Pty Ltd, is engaged in developing and commercializing drug therapies and drug discovery tools. The Company’s business activity focuses on the clinical development of the Company’s therapeutic product (DMX200), which is targeted at treatind patients with chronic kidney disease; the development of other therapeutic oppurtunities generated from the use of its cell-based drug discovery assay technology (know as Receptor-HIT), and growing its assay business through the use of Receptor-HIT to assist third parties in their own drug discovery and development processes through contract research. DMX200 is a therapeutic approach to treating chronic kidney disease. It comprises two drugs: irbesartan and propagermanium.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Health Disease Drugs Life Sciences Health Sciences Drug Discovery Therapeutic Product

    Is DXB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 20 Companies Like Dimerix (ASX:DXB) Can Afford To Invest In Growth
    Aug 31 Dimerix Full Year 2024 Earnings: AU$0.038 loss per share (vs AU$0.042 loss in FY 2023)
    May 27 Dimerix and Taiba enter DMX-200 commercialisation deal in Middle East
    May 23 Dimerix (ASX:DXB) shareholders have earned a 359% return over the last year
    See more DXB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.665
    52 Week Low 0.13
    Average Volume 2,051,599
    200-Day Moving Average 0.391
    50-Day Moving Average 0.400
    20-Day Moving Average 0.383
    10-Day Moving Average 0.369
    Average True Range 0.024
    RSI (14) 29.58
    ADX 17.74
    +DI 10.759
    -DI 33.144
    Chandelier Exit (Long, 3 ATRs) 0.378
    Chandelier Exit (Short, 3 ATRs) 0.372
    Upper Bollinger Bands 0.434
    Lower Bollinger Band 0.332
    Percent B (%b) -0.07
    BandWidth 26.646
    MACD Line -0.020
    MACD Signal Line -0.013
    MACD Histogram -0.0064
    Fundamentals Value
    Market Cap 64.31 Million
    Num Shares 198 Million
    EPS -0.02
    Price-to-Earnings (P/E) Ratio -18.06
    Price-to-Sales 0.00
    Price-to-Book 6.25
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.378
    Resistance 3 (R3) 0.375 0.355 0.369
    Resistance 2 (R2) 0.355 0.342 0.356 0.366
    Resistance 1 (R1) 0.340 0.333 0.330 0.343 0.363
    Pivot Point 0.320 0.320 0.315 0.321 0.320
    Support 1 (S1) 0.305 0.307 0.295 0.308 0.287
    Support 2 (S2) 0.285 0.298 0.286 0.284
    Support 3 (S3) 0.270 0.285 0.281
    Support 4 (S4) 0.273